DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy

Abstract

In this study, the solution chemistry of a chelator developed for 227Th targeted alpha therapy was probed. The compound of interest is an octadentate ligand comprising four N-methyl-3-hydroxy-pyridine-2-one metal-binding units, two tertiary amine groups, and one carboxylate arm appended for bioconjugation. The seven pKa values of the ligand and the stability constants of complexes formed with Th(IV), Hf(IV), Zr(IV), Gd(III), Eu(III), Al(III), and Fe(III) were determined. The ligand exhibits extreme thermodynamic selectivity toward tetravalent metal ions with a ca. 20 orders of magnitude difference between the formation constant of the Th(IV) species formed at physiological pH, namely [ThL]-, and that of its Eu(III) analogue. Likewise, log β110 values of 41.7 ± 0.3 and 26.9 ± 0.3 (T = 25 °C) were measured for [ThL]- and [FeIIIL]2-, respectively, highlighting the high affinity and selectivity of the ligand for Th ions over potentially competing endogenous metals. Single crystal X-ray analysis of the Fe(III) complex revealed a dinuclear 2:2 metal:chelator complex crystallizing in the space group P1-. The formation of this dimeric species is likely favored by several intramolecular hydrogen bonds and the protonation state of the chelator in acidic media. LIII edge EXAFS data on the Th(IV) complexes of both the ligandmore » and a monoclonal antibody conjugate revealed the expected mononuclear 1:1 metal:chelator coordination environment. This was also confirmed by high resolution mass spectrometry. Lastly, kinetic experiments demonstrated that labeling the bioconjugated ligand with Th(IV) could be achieved and completed after 1 h at room temperature, reinforcing the high suitability of this chelator for 227Th targeted alpha therapy.« less

Authors:
 [1]; ORCiD logo [2];  [1];  [1];  [2];  [3];  [3];  [3];  [3]; ORCiD logo [2]
  1. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  2. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States); Univ. of California, Berkeley, CA (United States)
  3. Bayer AS, Oslo (Norway)
Publication Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES). Chemical Sciences, Geosciences, and Biosciences Division
OSTI Identifier:
1510758
Grant/Contract Number:  
AC02-05CH11231; AC02-76SF00515
Resource Type:
Accepted Manuscript
Journal Name:
Inorganic Chemistry
Additional Journal Information:
Journal Volume: 57; Journal Issue: 22; Journal ID: ISSN 0020-1669
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; 62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats

Deblonde, Gauthier J. -P., Lohrey, Trevor D., Booth, Corwin H., Carter, Korey P., Parker, Bernard F., Larsen, Åsmund, Smeets, Roger, Ryan, Olav B., Cuthbertson, Alan S., and Abergel, Rebecca J. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy. United States: N. p., 2018. Web. doi:10.1021/acs.inorgchem.8b02430.
Deblonde, Gauthier J. -P., Lohrey, Trevor D., Booth, Corwin H., Carter, Korey P., Parker, Bernard F., Larsen, Åsmund, Smeets, Roger, Ryan, Olav B., Cuthbertson, Alan S., & Abergel, Rebecca J. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy. United States. https://doi.org/10.1021/acs.inorgchem.8b02430
Deblonde, Gauthier J. -P., Lohrey, Trevor D., Booth, Corwin H., Carter, Korey P., Parker, Bernard F., Larsen, Åsmund, Smeets, Roger, Ryan, Olav B., Cuthbertson, Alan S., and Abergel, Rebecca J. Mon . "Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy". United States. https://doi.org/10.1021/acs.inorgchem.8b02430. https://www.osti.gov/servlets/purl/1510758.
@article{osti_1510758,
title = {Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy},
author = {Deblonde, Gauthier J. -P. and Lohrey, Trevor D. and Booth, Corwin H. and Carter, Korey P. and Parker, Bernard F. and Larsen, Åsmund and Smeets, Roger and Ryan, Olav B. and Cuthbertson, Alan S. and Abergel, Rebecca J.},
abstractNote = {In this study, the solution chemistry of a chelator developed for 227Th targeted alpha therapy was probed. The compound of interest is an octadentate ligand comprising four N-methyl-3-hydroxy-pyridine-2-one metal-binding units, two tertiary amine groups, and one carboxylate arm appended for bioconjugation. The seven pKa values of the ligand and the stability constants of complexes formed with Th(IV), Hf(IV), Zr(IV), Gd(III), Eu(III), Al(III), and Fe(III) were determined. The ligand exhibits extreme thermodynamic selectivity toward tetravalent metal ions with a ca. 20 orders of magnitude difference between the formation constant of the Th(IV) species formed at physiological pH, namely [ThL]-, and that of its Eu(III) analogue. Likewise, log β110 values of 41.7 ± 0.3 and 26.9 ± 0.3 (T = 25 °C) were measured for [ThL]- and [FeIIIL]2-, respectively, highlighting the high affinity and selectivity of the ligand for Th ions over potentially competing endogenous metals. Single crystal X-ray analysis of the Fe(III) complex revealed a dinuclear 2:2 metal:chelator complex crystallizing in the space group P1-. The formation of this dimeric species is likely favored by several intramolecular hydrogen bonds and the protonation state of the chelator in acidic media. LIII edge EXAFS data on the Th(IV) complexes of both the ligand and a monoclonal antibody conjugate revealed the expected mononuclear 1:1 metal:chelator coordination environment. This was also confirmed by high resolution mass spectrometry. Lastly, kinetic experiments demonstrated that labeling the bioconjugated ligand with Th(IV) could be achieved and completed after 1 h at room temperature, reinforcing the high suitability of this chelator for 227Th targeted alpha therapy.},
doi = {10.1021/acs.inorgchem.8b02430},
journal = {Inorganic Chemistry},
number = 22,
volume = 57,
place = {United States},
year = {Mon Oct 29 00:00:00 EDT 2018},
month = {Mon Oct 29 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 30 works
Citation information provided by
Web of Science

Figures / Tables:

Table 1 Table 1: Alpha-particle emitters currently studied for medical applications.

Save / Share:

Works referenced in this record:

Advancements in cancer therapy with alpha-emitters: a review
journal, September 2001


The Radiochemical and Radiopharmaceutical Applications of Radium
journal, January 2016

  • Gott, Matthew; Steinbach, Jörg; Mamat, Constantin
  • Open Chemistry, Vol. 14, Issue 1
  • DOI: 10.1515/chem-2016-0011

Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides
journal, September 1976


The size of actinoid(III) ions – structural analysis vs. common misinterpretations
journal, July 2016


Abundance of chemical elements in the continental crust: a new table
journal, August 1964


Recovery of Uranium from Wet Phosphoric Acid by Solvent Extraction Processes
journal, November 2014

  • Beltrami, Denis; Cote, Gérard; Mokhtari, Hamid
  • Chemical Reviews, Vol. 114, Issue 24
  • DOI: 10.1021/cr5001546

Thorium Metallacycle Facilitates Catalytic Alkyne Hydrophosphination
journal, September 2017

  • Garner, Mary E.; Parker, Bernard F.; Hohloch, Stephan
  • Journal of the American Chemical Society, Vol. 139, Issue 37
  • DOI: 10.1021/jacs.7b08323

Solution thermodynamic evaluation of hydroxypyridinonate chelators 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO) for UO 2 (VI) and Th(IV) decorporation
journal, June 2013

  • Sturzbecher-Hoehne, M.; Deblonde, G. J. -P.; Abergel, R. J.
  • Radiochimica Acta, Vol. 101, Issue 6
  • DOI: 10.1524/ract.2013.2047

Rational Design of Sequestering Agents for Plutonium and Other Actinides
journal, November 2003

  • Gorden, Anne E. V.; Xu, Jide; Raymond, Kenneth N.
  • Chemical Reviews, Vol. 103, Issue 11
  • DOI: 10.1021/cr990114x

Using the Antenna Effect as a Spectroscopic Tool: Photophysics and Solution Thermodynamics of the Model Luminescent Hydroxypyridonate Complex [Eu III (3,4,3-LI(1,2-HOPO))]
journal, December 2009

  • Abergel, Rebecca J.; D’Aléo, Anthony; Ng Pak Leung, Clara
  • Inorganic Chemistry, Vol. 48, Issue 23
  • DOI: 10.1021/ic9013703

Chelation and stabilization of berkelium in oxidation state +IV
journal, April 2017

  • Deblonde, Gauthier J. -P.; Sturzbecher-Hoehne, Manuel; Rupert, Peter B.
  • Nature Chemistry, Vol. 9, Issue 9
  • DOI: 10.1038/nchem.2759

Highly Luminescent and Stable Hydroxypyridinonate Complexes: A Step Towards New Curium Decontamination Strategies
journal, July 2014

  • Sturzbecher-Hoehne, Manuel; Kullgren, Birgitta; Jarvis, Erin E.
  • Chemistry - A European Journal, Vol. 20, Issue 32
  • DOI: 10.1002/chem.201402103

Toxic heavy metal – Pb, Cd, Sn – complexation by the octadentate hydroxypyridinonate ligand archetype 3,4,3-LI(1,2-HOPO)
journal, January 2018

  • Deblonde, Gauthier J. -P.; Lohrey, Trevor D.; An, Dahlia D.
  • New Journal of Chemistry, Vol. 42, Issue 10
  • DOI: 10.1039/C7NJ04559J

From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents
journal, April 2017

  • An, Dahlia D.; Kullgren, Birgitta; Jarvis, Erin E.
  • Chemico-Biological Interactions, Vol. 267
  • DOI: 10.1016/j.cbi.2016.03.034

p -SCN-Bn-HOPO: A Superior Bifunctional Chelator for 89 Zr ImmunoPET
journal, November 2015


Gd−Hydroxypyridinone (HOPO)-Based High-Relaxivity Magnetic Resonance Imaging (MRI) Contrast Agents
journal, July 2009

  • Datta, Ankona; Raymond, Kenneth N.
  • Accounts of Chemical Research, Vol. 42, Issue 7
  • DOI: 10.1021/ar800250h

In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
journal, August 2016


Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in <i>in vitro</i> and <i>in vivo</i> models of renal cell carcinoma
journal, April 2017


An efficient chelator for complexation of thorium-227
journal, September 2016

  • Ramdahl, Thomas; Bonge-Hansen, Hanne T.; Ryan, Olav B.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 26, Issue 17
  • DOI: 10.1016/j.bmcl.2016.07.034

GLEE, a new computer program for glass electrode calibration
journal, January 2000


A short history of SHELX
journal, December 2007

  • Sheldrick, George M.
  • Acta Crystallographica Section A Foundations of Crystallography, Vol. 64, Issue 1, p. 112-122
  • DOI: 10.1107/S0108767307043930

WinGX and ORTEP for Windows : an update
journal, July 2012


X-ray-absorption fine-structure standards: A comparison of experiment and theory
journal, September 1995


Parameter-free calculations of X-ray spectra with FEFF9
journal, January 2010

  • Rehr, John J.; Kas, Joshua J.; Vila, Fernando D.
  • Physical Chemistry Chemical Physics, Vol. 12, Issue 21
  • DOI: 10.1039/b926434e

Thorium(IV) Complexes of Bidentate Hydroxypyridinonates 1
journal, April 2003

  • Xu, Jide; Whisenhunt, Donald W.; Veeck, Alan C.
  • Inorganic Chemistry, Vol. 42, Issue 8
  • DOI: 10.1021/ic0259888

Confirmation of standard error analysis techniques applied to EXAFS using simulations
journal, November 2009


Number of relevant independent points in x-ray-absorption fine-structure spectra
journal, October 1993


Gadolinium complex of tris[(3-hydroxy-1-methyl- 2-oxo-1,2-didehydropyridine-4-carboxamido)ethyl]-amine: A New Class of gadolinium magnetic resonance relaxation agents
journal, July 1995

  • Xu, Jide; Franklin, Sonya J.; Whisenhunt, Donald W.
  • Journal of the American Chemical Society, Vol. 117, Issue 27, p. 7245-7246
  • DOI: 10.1021/ja00132a025

Plutonium(IV) Sequestration: Structural and Thermodynamic Evaluation of the Extraordinarily Stable Cerium(IV) Hydroxypyridinonate Complexes1
journal, September 2000

  • Xu, Jide; Radkov, Emil; Ziegler, Marco
  • Inorganic Chemistry, Vol. 39, Issue 18, p. 4156-4164
  • DOI: 10.1021/ic000063i

A Macrocyclic Chelator with Unprecedented Th 4+ Affinity
journal, June 2014

  • Pham, Tiffany A.; Xu, Jide; Raymond, Kenneth N.
  • Journal of the American Chemical Society, Vol. 136, Issue 25
  • DOI: 10.1021/ja503456r

3,4,3-LI(1,2-HOPO): In vitro formation of highly stable lanthanide complexes translates into efficacious in vivo europium decorporation
journal, January 2011

  • Sturzbecher-Hoehne, Manuel; Ng Pak Leung, Clara; D'Aléo, Anthony
  • Dalton Transactions, Vol. 40, Issue 33
  • DOI: 10.1039/c1dt10840a

Hexadentate Hydroxypyridonate Iron Chelators Based on TREN-Me-3,2-HOPO:  Variation of Cap Size1
journal, November 2002

  • Xu, Jide; O'Sullivan, Brendon; Raymond, Kenneth N.
  • Inorganic Chemistry, Vol. 41, Issue 25
  • DOI: 10.1021/ic025610+

N-Carboxyalkyl derivatives of 3-hydroxy-4-pyridinones: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation
journal, September 2002


Works referencing / citing this record:

Ultra-selective ligand-driven separation of strategic actinides
journal, June 2019

  • Deblonde, Gauthier J. -P.; Ricano, Abel; Abergel, Rebecca J.
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-10240-x

A Thorium Metal‐Organic Framework with Outstanding Thermal and Chemical Stability
journal, April 2019

  • Carter, Korey P.; Ridenour, J. August; Kalaj, Mark
  • Chemistry – A European Journal, Vol. 25, Issue 29
  • DOI: 10.1002/chem.201901610

Ultra-selective ligand-driven separation of strategic actinides
journal, June 2019

  • Deblonde, Gauthier J. -P.; Ricano, Abel; Abergel, Rebecca J.
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-10240-x

Synergistic Effect of a Mesothelin-Targeted 227 Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
journal, March 2019

  • Wickstroem, Katrine; Hagemann, Urs B.; Cruciani, Véronique
  • Journal of Nuclear Medicine, Vol. 60, Issue 9
  • DOI: 10.2967/jnumed.118.223701